University Ramon Llull

Westinghouse Appoints Lou Martinez Sancho as Chief Technology Officer

Retrieved on: 
Monday, January 29, 2024
Nuclear, Energy, Utilities, Westinghouse Electric Company, Supply, Architecture, Multimedia, Massachusetts Institute of Technology, Innovation, University Ramon Llull, Ohio State University, Engineering, Westinghouse, Communication, The Electric Company, AEC, Spie Batignolles, Management

Westinghouse Electric Company announced today the appointment of Lou Martinez Sancho as Chief Technology Officer and Executive Vice President of R&D and Innovation.

Key Points: 
  • Westinghouse Electric Company announced today the appointment of Lou Martinez Sancho as Chief Technology Officer and Executive Vice President of R&D and Innovation.
  • In this role, Martinez Sancho will lead the company’s global research and development portfolio and advance the company’s innovative product and services technology strategy.
  • View the full release here: https://www.businesswire.com/news/home/20240129140784/en/
    Westinghouse announced today the appointment of Lou Martinez Sancho as Chief Technology Officer and Executive Vice President of R&D and Innovation.
  • (Photo: Business Wire)
    “For decades, Westinghouse has pioneered ideas that have shaped tomorrow’s energy future,” said Patrick Fragman, Westinghouse President and Chief Executive Officer.

Titan Partners Group Announces Addition of Dr. David Sans as Head of Healthcare

Retrieved on: 
Monday, March 27, 2023
Titan, Drug development, Avista Capital Partners, Doctor of Philosophy, ETH, Cetuximab, National Comprehensive Cancer Network, Wall Street, Head, American Academy, MBA, Acute leukemia, Multiple sclerosis, Partners Group, Eli Lilly, Regenerative medicine, Novartis, Chemical engineering, FINRA, Interferon beta-1a, University Ramon Llull, BMS, Medtech, ImClone Systems, Pfizer, Pharmaceutical industry, Imatinib

NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Titan Partners Group LLC, a division of American Capital Partners, LLC (“Titan Partners”), announces today that Dr. David Sans has joined the firm as head of healthcare.

Key Points: 
  • NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Titan Partners Group LLC, a division of American Capital Partners, LLC (“Titan Partners”), announces today that Dr. David Sans has joined the firm as head of healthcare.
  • Dr. Sans will lead the healthcare team, which covers companies in the biopharmaceuticals, diagnostics, medtech and specialty pharmaceuticals sectors.
  • “We are excited to bring in David Sans to join Titan Partners and lead our healthcare practice as we continue to expand our footprint and capacity in this sector,” commented Michael Sands, Titan Partners co-founder and partner.
  • Titan Partners is committed to building out a leading healthcare division.

Wee-Cig International Corp. Signs Definitive Agreement to Acquire Controlling Interest in The Jamaican Brew House

Retrieved on: 
Monday, February 6, 2023
Marketing, Economics, Cannabis, Mining, Corporation, Acquisition, KSS, Bias, Nobility, University Ramon Llull, FMB, House, Cayman Islands, Patent, Multinational corporation, Brew House Association, Food, Commerce, Growth, Coffee, Management

With this acquisition, management is eager to enter the cannabis industry with such a strong and innovative partner.

Key Points: 
  • With this acquisition, management is eager to enter the cannabis industry with such a strong and innovative partner.
  • The Jamaican Brew House team, including leaders in sales, marketing, food processing and corporate advisory bring their deep industry knowledge to our operations.
  • "We are excited to announce entry into a definitive agreement to acquire a controlling interest in The Jamaican Brew House,” said Efraim Babayov, President of Wee-Cig International Corporation.
  • “Kickstarting commercial sales for The Jamaican Brew House products is expected to be the focus of Wee-Cig in 2023.

The Cognitive Shortcut That Clouds Decision-Making

Retrieved on: 
Wednesday, August 17, 2022
Risk, Social, Face, MIT Sloan Management Review, MIT Sloan School of Management, ESADE Business School, Leadership, University of Cologne, Environment, Purdue University, Center, Decision-making, MIT, University Ramon Llull, Bias, Culture, University, EDT, Organization, Public relations, Management

CAMBRIDGE, Mass., Aug. 17, 2022 /PRNewswire/ -- New research released today in MIT Sloan Management Review, examines how inaccurate or false information, if repeated often enough, can acquire an illusion of truth, thereby placing executive decision-making at risk.

Key Points: 
  • Leaders can find themselves on the receiving end of falsified data, facts, and figures.
  • Misinformation, regardless of whether it was mistakenly passed along or shared with ill intent, is a common occurrence in this digital age.
  • Beware of bias blind spots, maintain as accuracy mindset, perform external fact-checking, and don't get stuck in an epistemic bubble.
  • The MIT Sloan Management Review (MIT SMR) article, " The Cognitive Shortcut that Clouds Decision-Making ,"publishes at 8 a.m. EDT on August 17, 2022.

Prescient Announces Recent Appointments to Its Senior Advisory Team and the Opening of Its 10th Location

Retrieved on: 
Wednesday, June 29, 2022
Leadership, European Advisory Commission, Science, University Ramon Llull, Bachelor of Science, IESE Business School, Autonomous University of Barcelona, Growth, Industry, MBA, Lundbeck, Marketing, KPMG, Autonomous university, Sanofi, City, Foreknowledge, IQVIA, Medicine, Universitat (Barcelona Metro), Associate, Bridgepoint Advisers, Management, Fine chemical, Engineering

LONDON, June 29, 2022  /PRNewswire/ -- Prescient, a biopharma product and portfolio strategy firm, has announced the recent appointments of Dr. Olga Fidalgo González and Claudio Jouanneau as leaders in its Advisory business. Prescient has also expanded its global footprint with a new office in Barcelona.

Key Points: 
  • LONDON, June 29, 2022 /PRNewswire/ -- Prescient, a biopharma product and portfolio strategy firm, has announced the recent appointments of Dr. Olga Fidalgo Gonzlez and Claudio Jouanneau as leaders in its Advisory business.
  • At Prescient, Olga is responsible for championing the development of the Barcelona-based Advisory team, contributing to growing our European Advisory business and supporting our clients to address their strategic and operational challenges.
  • At Prescient, Claudio is responsible for building our Spanish Advisory team and supporting the growth of our European Advisory business.
  • Prescient has been a portfolio company of Bridgepoint Development Capital since 2021 and Baird Capital since 2017.